Showing results (141-150 of 201) with videos related to

Sort By:
Pageof 21
Journal of Clinical Pharmacology|February 22, 2023
Evaluation of the Impact of Ritlecitinib on Organic Cation Transporters Using Sumatriptan and Biomarkers as ProbesXiaoxing Wang, Vivek Purohit, Martin E Dowty, et al.
Archives of Dermatology|March 23, 2005
Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapyChristiane Querfeld, Steven T Rosen, Timothy M Kuzel, et al.
Wiener Medizinische Wochenschrift (1946)|July 13, 2026
Prevalence and potential associations of the 2022 newly introduced monocyte value for diagnosis of chronic myelomonocytic leukemia in a general Austrian populationK Geissler, M Azizzadeh, C Gross, et al.
Vaccine|July 25, 2006
Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse modelAnne K Shriner, S Louise Smithson, Deborah M Prinz, et al.
Scientific Reports|January 20, 2016
Optically induced mode splitting in self-assembled, high quality-factor conjugated polymer microcavitiesDaniel Braam, Soh Kushida, Robert Niemöller, et al.
Transplantation|January 16, 2004
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipientsGalya Dragieva, Jürg Hafner, Reinhard Dummer, et al.
BJU International|March 31, 2004
Over-expression of anti-CD75 reactive proteins on distal and collecting renal tubular epithelial cells in calcium-oxalate stone-forming kidneys in EgyptG Kramer, G E Steiner, C Neumayer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2011
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderlyK Fritsch, B Kasenda, C Hader, et al.
Clinical and Translational Science|December 8, 2020
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF-06826647: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation StudyRavi Shankar P Singh, Vivek Pradhan, Erika S Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonistsKenneth M Meyers, José Méndez-Andino, Anny-Odile Colson, et al.
Pageof 21